<DOC>
	<DOCNO>NCT00264940</DOCNO>
	<brief_summary>The prevalence type 2 diabetes rise population many year . It recognize period glucose intolerance precedes clinical symptom appearance . This due combination b-cell dysfunction insulin resistance . It estimate pre-clinical phase type 2diabetes may antedate onset overt diabetes 10-12 year . Furthermore , insulin resistance consider main component metabolic syndrome associate significant cardiovascular morbidity mortality . Recently , effort pinpoint pre-diabetic phase early therapeutic intervention individual . These study , patient impair glucose intolerance , show beneficial lifestyle change pharmacological intervention . It thus hypnotize intervention patient insulin resistance without glucose intolerance may prevent progress type 2 diabetes â€™ complication . There difficulty identify individual high risk type 2 diabetes . The prevention strategy rely intervention pre-diseased state . In case type 2 diabetes , early intervention useful phase insulin resistance , prior appearance glucose intolerance . The diagnosis insulin resistance challenge one . The gold standard diagnose insulin resistance hyperinsulinemic-euglycemic clamp , method suitable routine clinical use . Thus , less invasive method evaluation , like homeostasis model assessment ( HOMA ) quantitative insulin sensitivity check index ( QUICKI ) , develop . There correlation HOMA QUICKI result hyperinsulinemic-euglycemic clamp . Both HOMA QUICKI allow insulin resistance diagnosis . The result test correlate hyperinsulinemic-euglycemic clamp allow diagnose insulin resistance , however , index require serum glucose , insulin measurement quite complicate calculation . A new method suggest , non-invasive , sensitive simple , identification insulin resistance . In normal individual , presence insulin , glucose take variety cell , undergoes glycolysis enters tricarboxylic acid cycle fat synthesis . In either case , CO2 produce by-product . This CO2 enter circulation discard lung . The new method base assumption 13C-glucose ingested describe by-product 13CO2 measure expire air . In type 2 diabetes state insulin resistance glucose , uptake impaired result blunt 13CO2 production . This hypothesis test Lewanczuc et al . The writer compare [ 13C ] -glucose breath test hyperinsulinemic-euglycemic clamp , HOMA QUICKI index . They test 26 patient different stage insulin sensitivity report good correlation glucose breath test index . We suggest test large group patient high-risk develop type 2 diabetes compare glucose breath test HOMA index .</brief_summary>
	<brief_title>Diagnosis Insulin Resistance : 13C-Glucose Breath Test Vs HOMA Index .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Must able fast night A blood sample drawn Insulin dependent diabetes Pulmunary disorder Gastrointestinal disorder Endocrine disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2005</verification_date>
</DOC>